Prodigy Investment Co., Ltd.

Prodigy Investment Co., Ltd. (Korean: 프로디지인베스트먼트; also styled Prodigy Inv) is a South Korean venture capital firm. It was established in December 2017 by CEO Han Kyu-jeong, who previously worked at ATINUM Investment, with initial capital of KRW 2 billion. The firm is headquartered in Seoul and operates as a private, independent investment house focused on venture and growth-stage companies in South Korea. Prodigy Investment builds and manages investment funds, or partnerships, through which it deploys capital into promising Korean businesses. In 2019 it formed its second investment partnership, 'Prodigy No. 2 Investment Partnership,' with a fund size of KRW 7 billion. The firm has backed companies across sectors including healthcare, biotechnology, media, and advanced manufacturing. Among its disclosed portfolio companies are SsiSight (씨싸이트), which it invested in through NH SPAC No. 28 and which later merged with that SPAC; Halla Cast (한라캐스트), for which it acquired KRW 10 billion worth of convertible bonds; MetaFines (메타파인즈); Flugo (플루고); and IMBiologics (아이엠바이오로직스), in which it made a pre-IPO investment in 2025. These investments illustrate the firm's focus on both listed-company transactions and private growth companies. As a relatively young and privately held venture capital firm, Prodigy Investment does not disclose extensive public financials. Its official website serves as its primary public presence. The firm remains active in the Korean venture capital market, continuing to source and manage investments in early- and growth-stage companies.

Prodigy Investment Co., Ltd. was founded in December 2017 by Han Kyu-jeong, a former executive at ATINUM Investment. The firm was established with initial capital of KRW 2 billion. Han Kyu-jeong serves as its CEO. In 2019, Prodigy Investment formed its second investment partnership, 'Prodigy No. 2 Investment Partnership,' with a fund size of KRW 7 billion. This marked a significant step in the firm's fundraising and investment capacity. The firm has since built a portfolio of investments across various sectors. Notable investments include SsiSight (씨싸이트), where Prodigy invested through NH SPAC No. 28, leading to a merger between SsiSight and the SPAC; Halla Cast (한라캐스트), where Prodigy acquired KRW 10 billion worth of convertible bonds; MetaFines (메타파인즈); Flugo (플루고); and IMBiologics (아이엠바이오로직스), which received a pre-IPO investment from Prodigy in 2025. As of the latest available information, Prodigy Investment remains an active, privately held venture capital firm based in South Korea.

• 2025

  Made a pre-IPO investment in IMBiologics.

• 2019

  Formed 'Prodigy No. 2 Investment Partnership' with a fund size of KRW 7 billion.

• 2017

  Founded by Han Kyu-jeong with KRW 2 billion in capital.

Independent South Korean venture capital firm focused on venture and growth-stage investments.

• Prodigy No. 2 Investment Partnership

  A KRW 7 billion investment fund formed in 2019.

1. 1Prodigy Inv - Wikidatawikidata.org
2. 2프로디지인베스트먼트 - Wikipedia (Korean)ko.wikipedia.org